ADURO BIOTECH, INC.
740 Heinz Avenue
Berkeley, California 94710
(510) 848-4400
August 9, 2017
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
| Attn: | Ada Sarmento | |||
| Re: | Aduro Biotech, Inc. | |||
| Registration Statement on Form S-3 | ||||
| File No. 333-219640 | ||||
| Acceleration Request | ||||
| Requested Date: | Friday, August 11, 2017 | |||
| Requested Time: | 4:00 p.m., Eastern Time | |||
Ladies and gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant hereby requests that the Securities and Exchange Commission take appropriate action to cause the above referenced Registration Statement on Form S-3 to become effective on August 11, 2017, at 4:00 p.m., Eastern Time, or as soon as practicable thereafter.
| Very truly yours, | ||
| Aduro Biotech, Inc. | ||
| By: | /s/ Jennifer Lew | |
| Name: | Jennifer Lew | |
| Title: | Senior Vice President of Finance | |
| cc: | Stephen T. Isaacs, Aduro Biotech, Inc. |
Blaine Templeman, Aduro Biotech, Inc.
Michael E. Tenta, Cooley LLP
J. Carlton Fleming, Cooley LLP